A model for treatment strategy in the chemotherapy of AIDS (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literature

• Agur, Z. 1989. A new method for reducing cytotoxicity of the anti-AIDS drug AZT. In_Biomedical Modeling and Simulation_, D. S. Levine, (Ed), pp. 59–61. J. C. Baltzer AG, Scientific Publishing.
• Anderson, D. J.,et al.. 1992. Effects of disease stage and AZT therapy on the detection of HIV-1 in semen.J. Amer. Med. Assoc. 267, 2769–2774.
  Article Google Scholar
• Chow, Y. K.,et al. 1993. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.Nature 361, 650–655.
  Article Google Scholar
• Cojocaru, L. and Z. Agur. 1992. A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs.Math. Biosci. 109, 85–97.
  Article MATH Google Scholar
• Cojocaru, L. and Z. Agur. 1993. New mathematical methods for evaluating toxicity of anti-cancer drugs and AZT. Preprint.
• Concorde Coordinating Committee. 1994. MRC/ANRS randomized double-blind controlled trial of immediate and deferred AZT in symptom-free HIV infection.Lancet 343, 871–881.
  Article Google Scholar
• Cooper, D. A.,et al. 1991. The efficacy and safety of AZT with or without acyclovir in the treatment of patients with AIDS related complex.AIDS 5, 933–943.
  Google Scholar
• Cox, H. P.,et al. 1990. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.Nurse Practitioner 15, 36–43.
  Article Google Scholar
• Dimitrov, D. S.et al. 1993. Quantitation of HIV-type 1 infection kinetics.J. Virology 67, 2182–2190.
  MathSciNet Google Scholar
• Fischl, M. A.,et al. 1990. The safety and efficacy of AZT in the treatment of subjects with mildly symptomatic HIV type 1.Ann. Int. Med. 112, 727–737.
  Google Scholar
• Graham, N. M. H.,et al. 1992. The effects on survival of early treatment of HIV infection.New Engl. J. Med. 326, 1037–1042.
  Article Google Scholar
• Hamilton, J. D.,et al. 1992. A controlled trial of early vs. late treatment with AZT in symptomatic HIV infection.New Engl. J. Med. 326, 437–443.
  Article Google Scholar
• Harnevo, L. E. 1993. Simple models for interactions of the HIV and the immune system: can we point to a specific threshold for the onset of AIDS? In_Proceedings of the World Congress for Non-linear Analysts_. To appear.
• Haseltine, W. A. and F. Wong-Staal. 1988. The molecular biology of the AIDS virus.Scientific American October, 53–62.
  Google Scholar
• Hirsch, M. S. 1990. Chemotherapy of HIV infections: Current practice and future prospects.J. Infectious Diseases 161, 845–857.
  Google Scholar
• Ho, D. D.,et al. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.Nature 373, 123–126.
  Article Google Scholar
• Kaiser, J. D. 1993.Immune Power. New York: St. Martin's Press.
  Google Scholar
• Kirschner, D., R. Mehr and A. Perelson. 1995. The role of the thymus in HIV infection. Preprint.
• Kirschner, D. and A. Perelson. 1995. A model for the immune system response to HIV: AZT treatment studies. In_Mathematical Populations Dynamics III. Theory of Epidemics_, O. Arino, D. Axelrod and M. Kimmel (Eds), Vol. 1, pp. 295–310. Winnepeg, Manitoba: Wuerz Publishing.
  Google Scholar
• Kirschner, D. E. and G. F. Webb, 1995. Effects of drug resistance on chemotherapy strategies in the treatment of HIV infection. Preprint.
• Lagakos, S., C. Pettinelli, D. Stein and P. A. Volderding. 1993. The Concorde Trial.Lancet 341, 1276.
  Article Google Scholar
• Landonio, G.et al. 1993. Comparison of two dose regimes of AZT in an open, randomized, multicetre study for severe HIV-related thromocytopenia.AIDS 7, 209–212.
  Google Scholar
• Lenderking, W. R.,et al. 1994. Evaluation of the quality of life associated with Zidovudine treatment in asymptomatic human immunodeficiency virus infection.New. Engl. J. Med. 330, 738–743.
  Article Google Scholar
• Lundgren, J. D.,et al. 1994. Comparison of long-term prognosis of patients with AIDS treated and not treated with Zidovudine.J. Amer. Med. Assoc. 271, 1088–1092.
  Article Google Scholar
• McKallip, R. J., M. Nagarkatti and P. S. Nagarkatti. 1995. Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell response to gp120 of HIV.Tox. Appl. Pharm. 131, 53–63.
  Article Google Scholar
• McLean, A. and M. Nowak, 1991. Interactions between HIV and other pathogens.J. Theoret. Biol. 155, 69–86.
  Article Google Scholar
• McLean, A. and M. Nowak. 1992. Competition between AZT sensitive and AZT resistant strains of HIV.AIDS 6, 71–79.
  Google Scholar
• McLeod, G. X. and S. M. Hammer. 1992. Zidovudine: 5 years later.Ann. Int. Med. 117, 487–501.
  Google Scholar
• Meng, T. C.,et al. 1992. Combination therapy with AZT and DDC in patients with advanced HIV infection.Ann. Int. Med. 116, 13–19.
  Google Scholar
• Montaner, J.,et al. 1993. Clinical correlates of_in vitro_ HIV-1 resistance to AZT.AIDS 7, 189–196.
  Google Scholar
• Mulder, J. W.,et al. 1994. AZT twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study.AIDS 8, 313–321.
  Article Google Scholar
• Nozyce, M.,et al. 1994. A 12-month study of the effects of oral AZT on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children.AIDS 8, 635–639.
  Google Scholar
• Perelson, A. S. 1989. Modeling the interaction of the immune system with HIV. In_Mathematical and Statistical Approaches to AIDS Epidermiology. Lecture Notes in Biomath._, C. Castillo-Chavez (Ed), Vol. 83, pp. 350–370. New York: Springer-Verlag.
  Google Scholar
• Perelson, A., D. Kirschner and R. DeBoer. 1993. The dynamics of HIV infection of CD4+ T cells.Math. Biosci. 114, 81–125.
  Article MATH Google Scholar
• Redfield, R. and D. Burke. 1988. HIV infection: The clinical picture.Scientific American October, 90–98.
  Article Google Scholar
• Ruedy, J., M. Schechter and J. S. G. Montaner. 1990. Zidovudine for early HIV infection: who, when and how?Ann. Int. Med. 112, 721–722.
  Google Scholar
• Volberding, P. A. 1994. Intermittent therapy.AIDS 7, 454–456.
  Google Scholar
• Volberding, P. A.,et al. 1990. Zidovudine in asymptomatic human immunodeficiency virus infection.New Engl. J. Med. 322, 941–949.
  Article Google Scholar
• Volderding, P. A.,et al., 1994. The duration of Zidovudine benefit in persons with asymptomatic HIV infection.J. Amer. Med. Assoc. 272, 437–442.
  Article Google Scholar
• Wolfram, S. A. 1988.Mathematica: A System for Doing Mathematics by Computer. Reading, MA: Addison-Wesley.
  MATH Google Scholar

Download references